Azithromycin plus hydroxychloroquine
IT005-501
Phase 3 small_molecule terminated
Quick answer
Azithromycin plus hydroxychloroquine for Respiratory Tract Infection Viral is a Phase 3 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iterum Therapeutics plc
- Indication
- Respiratory Tract Infection Viral
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated